Jiutian Chemical Group Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Jiutian Chemical Group ha aumentado sus beneficios a una tasa media anual de 9%, mientras que los beneficios de la industria de Chemicals han experimentado un descenso anual de 10.3%. Los ingresos han ido creciendo a una tasa media de 5.2% al año.

Información clave

9.0%

Tasa de crecimiento de los beneficios

12.0%

Tasa de crecimiento del BPA

Crecimiento de la industria Chemicals	0.9%
Tasa de crecimiento de los ingresos	5.2%
Rentabilidad financiera	-37.0%
Margen neto	-68.3%
Última actualización de beneficios	31 Mar 2024

Actualizaciones de resultados anteriores recientes

Recent updates

Desglose de ingresos y gastos
Beta

Cómo gana y gasta dinero Jiutian Chemical Group. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).

Historial de beneficios e ingresos

Catalist:C8R Ingresos, gastos y beneficios (CNY Millions)
Fecha	Ingresos	Beneficios	Gastos G+A
31 Mar 24	412	-282	49
31 Dec 23	599	-345	49
30 Sep 23	958	-220	59
30 Jun 23	1,398	-57	59
31 Mar 23	2,014	178	63
31 Dec 22	2,435	490	63
30 Sep 22	2,819	587	67
30 Jun 22	2,716	550	67
31 Mar 22	2,386	436	65
31 Dec 21	2,173	325	65
30 Sep 21	1,707	304	37
30 Jun 21	1,558	299	47
31 Mar 21	1,386	261	42
31 Dec 20	1,146	174	36
30 Sep 20	956	-150	38
30 Jun 20	934	-200	40
31 Mar 20	953	-239	41
31 Dec 19	1,054	-248	46
30 Sep 19	1,183	-4	41
30 Jun 19	1,227	-31	42
31 Mar 19	1,283	-8	45
31 Dec 18	1,308	22	47
30 Sep 18	1,338	43	53
30 Jun 18	1,282	80	51
31 Mar 18	1,180	88	48
31 Dec 17	1,124	71	47
30 Sep 17	1,003	37	48
30 Jun 17	915	25	46
31 Mar 17	830	5	47
31 Dec 16	709	1	41
30 Sep 16	610	-12	40
30 Jun 16	598	-15	39
31 Mar 16	649	-19	37
31 Dec 15	678	-9	39
30 Sep 15	782	6	40
30 Jun 15	870	14	40
31 Mar 15	861	23	40
31 Dec 14	937	27	40
30 Sep 14	942	31	46
30 Jun 14	927	29	45
31 Mar 14	1,002	30	47
31 Dec 13	971	21	51
30 Sep 13	975	24	52
30 Jun 13	990	23	57

Ingresos de calidad: C8R actualmente no es rentable.

Margen de beneficios creciente: C8R actualmente no es rentable.

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Tendencia de beneficios: C8R no es rentable, pero ha reducido pérdidas en los últimos 5 años a un ritmo de 19.5% por año.

Acelerando crecimiento: No se puede comparar el crecimiento de los beneficios de C8R en el último año con su promedio de 5 años, ya que actualmente no es rentable.

Beneficios vs. Industria: C8R no es rentable, por lo que resulta difícil comparar el crecimiento de sus beneficios en el último año con el de la industria Chemicals (-52.4%).

Rentabilidad financiera

Alta ROE: C8R tiene una rentabilidad financiera negativa (-37.04%), ya que actualmente no es rentable.

Jiutian Chemical Group Resultados de beneficios anteriores

Pasado controles de criterios 0/6

Información clave

Actualizaciones de resultados anteriores recientes

First quarter 2024 earnings released: CN¥0.024 loss per share (vs CN¥0.056 loss in 1Q 2023)

Full year 2023 earnings released: CN¥0.17 loss per share (vs CN¥0.25 profit in FY 2022)

Full year 2023 earnings released: CN¥0.17 loss per share (vs CN¥0.25 profit in FY 2022)

Jiutian Chemical Group Limited to Report Fiscal Year 2023 Results on Feb 29, 2024

Third quarter 2023 earnings released

Second quarter 2023 earnings released: CN¥0.026 loss per share (vs CN¥0.093 profit in 2Q 2022)

Recent updates

Jiutian Chemical Group Limited Announces Appointments and Changes to the Composition of Board of Directors and Board Committees

First quarter 2024 earnings released: CN¥0.024 loss per share (vs CN¥0.056 loss in 1Q 2023)

Full year 2023 earnings released: CN¥0.17 loss per share (vs CN¥0.25 profit in FY 2022)

Jiutian Chemical Group Limited Announces Retirement of Chan Kam Loon as Non-Executive and Independent Director

Jiutian Chemical Group Limited, Annual General Meeting, Apr 25, 2024

Full year 2023 earnings released: CN¥0.17 loss per share (vs CN¥0.25 profit in FY 2022)

Jiutian Chemical Group Limited to Report Fiscal Year 2023 Results on Feb 29, 2024

New major risk - Share price stability

Third quarter 2023 earnings released

New minor risk - Share price stability

New major risk - Dividend sustainability

Second quarter 2023 earnings released: CN¥0.026 loss per share (vs CN¥0.093 profit in 2Q 2022)

Jiutian Chemical Group Limited to Report First Half, 2023 Results on Aug 14, 2023

Now 22% undervalued after recent price drop

Jiutian Chemical Group Limited Declares Interim Tax Exempt (One-Tier) Dividend for the Financial Year 2023, Payable on 16 June 2023

Full year 2022 earnings released: EPS: CN¥0.25 (vs CN¥0.16 in FY 2021)

Full year 2022 earnings released: EPS: CN¥0.25 (vs CN¥0.16 in FY 2021)

Insufficient new directors

Third quarter 2022 earnings released

Second quarter 2022 earnings released: EPS: CN¥0.093 (vs CN¥0.035 in 2Q 2021)

Consensus forecasts updated

Jiutian Chemical Group Limited Provides Profit Guidance for Half Year Ended 30 June 2022

Jiutian Chemical Group Limited Approves the Appointment of Song Fudong as the Non-Executive and Non-Independent Director

Consensus revenue estimates increase by 18%

First quarter 2022 earnings: EPS and revenues exceed analyst expectations

Insufficient new directors

Jiutian Chemical Group Limited Announces Final Tax Exempt Dividend for the Financial Year Ended 31 December 2021, Payable on 27 May 2022

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Jiutian Chemical Group Limited Announces Re-Designation of Gao Guoan as Non-Executive and Non-Independent Director, Effective 26 April 2022

Consensus revenue estimates increase by 20%

Jiutian Chemical Group Limited Proposes Final Tax Exempt Dividend for the Financial Year Ended 31 December 2021

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Executive Director recently bought S$219k worth of stock

Third quarter 2021 earnings released: EPS CN¥0.029 (vs CN¥0.029 in 3Q 2020)

Executive Director recently sold S$2.4m worth of stock

Jiutian Chemical Group Limited Declares Interim Dividend, Payable on June 18, 2021

Consensus EPS estimates increase to CN¥0.14

Full year 2020 earnings released: EPS CN¥0.094 (vs CN¥0.14 loss in FY 2019)

Full year 2020 earnings released

Revenue and earnings miss expectations

Executive Director recently bought S$90k worth of stock

Jiutian Chemical Group Limited has completed a Follow-on Equity Offering in the amount of SGD 10.251 million.

First half earnings released

Desglose de ingresos y gastosBeta

Historial de beneficios e ingresos

Análisis del flujo de caja libre vs. Beneficios

Análisis del crecimiento de los beneficios en el pasado

Rentabilidad financiera

Rentabilidad económica

Rendimiento del capital invertido

Descubre empresas con buenos resultados en el pasado

Desglose de ingresos y gastos
Beta